Earum Pharmaceuticals Rights Issue 2023 vs Suven Life Sciences Rights Issue 2022

Comparision between Earum Pharmaceuticals Rights Issue 2023 and Suven Life Sciences Rights Issue 2022.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Earum Pharmaceuticals Rights Issue 2023 and Suven Life Sciences Rights Issue 2022. Earum Pharmaceuticals Rights Issue 2023 is listed on BSE while Suven Life Sciences Rights Issue 2022 is listed on BSE, NSE.

	Earum Pharmaceuticals Limited	Suven Life Sciences Limited
Logo
Listing At	BSE	BSE, NSE
Terms of Payment	Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call.	The full amount of Rs. 55 per share has to be paid at the time of Application.
Entitlement	4 Equity Shares for every 1 Equity Shares held on the Record Date	1 Equity Shares for every 2 Equity Shares held on the Record Date
Application Form	Application Form	Application Form
Letter of Offer	Letter of Offer	Letter of Offer
Registrar	Bigshare Services Pvt Ltd	Kfin Technologies Limited
Lead Managers	Axis Bank Limited	Ernst & Young Merchant Banking Services Llp

Rights Issue Size and Price

The issue size of Earum Pharmaceuticals Rights Issue 2023 rights issue is ₹49.34 Crores, whereas Suven Life Sciences Rights Issue 2022 rights issue size is ₹399.80 Crores.

	Earum Pharmaceuticals Limited	Suven Life Sciences Limited
Issue Size	24,67,16,400 shares	7,26,91,239 shares
Issue Size (Amount)	₹49.34 Crores	₹399.80 Crores
Issue Price	₹2 per share	₹55 per share
Face Value	₹2 per share	₹1 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Earum Pharmaceuticals Rights Issue 2023 is Apr 10, 2023 while record date of Suven Life Sciences Rights Issue 2022 is Oct 18, 2022.

	Earum Pharmaceuticals Limited	Suven Life Sciences Limited
Record Date	Apr 10, 2023	Oct 18, 2022
Credit of Rights Entitlements	Apr 26, 2023	Oct 28, 2022
Bid/Offer Opens On	May 02, 2023	Oct 31, 2022
Renunciation of Rights Entitlements	May 26, 2023	Nov 03, 2022
Bid/Offer Closes On	May 31, 2023	Nov 10, 2022
Deemed Date of Allotment	Jun 20, 2023	Nov 18, 2022
Credit Date	Jun 21, 2023	Nov 21, 2022
Listing Date	Jun 26, 2023	Nov 24, 2022

Financials details

Comparison of Earum Pharmaceuticals Rights Issue 2023 and Suven Life Sciences Rights Issue 2022 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

Earum Pharmaceuticals Limited

Suven Life Sciences Limited

Financial

Earum Pharmaceuticals Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Reserves and Surplus
31-Mar-20	36.16	57.38	1.82	8.25
31-Mar-21	27.87	50.02	0.09	8.33
31-Mar-22	28.79	28.74	2.22	4.39
Amount in ₹ Crore

Suven Life Sciences Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax
31-Mar-21	128.42	21.23	-72.15
31-Mar-22	108.03	17.16	-122
Amount in ₹ Crore

Compare with others

Earum Pharmaceuticals Limited	Suven Life Sciences Limited
Hilton Metal Forging Rights Issue 2022	Compuage Infocom Rights Issue 2022
Suven Life Sciences Rights Issue 2022	Rungta Irrigation Rights Issue 2022
Heritage Foods Rights Issue 2022	Transwarranty Finance Rights Issue 2022
Suzlon Energy Rights Issue 2022	Samor Reality Rights Issue 2022
Libas Consumer Products Rights Issue 2022	Hilton Metal Forging Rights Issue 2022
Suditi Industries Rights Issue 2022	Heritage Foods Rights Issue 2022
Destiny Logistic & Infra Rights Issue 2022	Suzlon Energy Rights Issue 2022
Gautam Gems Rights Issue 2022	Libas Consumer Products Rights Issue 2022
Coastal Corporation Rights Issue 2022	Earum Pharmaceuticals Rights Issue 2023
7NR Retail Rights Issue 2022	Suditi Industries Rights Issue 2022

Comments

Add a public comment...